QT
NUVB icon

Quantbot Technologies’s Nuvation Bio NUVB Stock Holding History

Quantbot Technologies’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,695
Closed -$15.2K – 2024
2025
Q4 		$15.2K Buy
+1,695
New +$10.5K ﹤0.01% 1580
2025
Q2 		– Sell
-23,897
Closed -$42.1K – 1848
2025
Q1 		$42.1K Sell
23,897
-7,448
-24% -$17K ﹤0.01% 1333
2024
Q4 		$83.4K Sell
31,345
-40,881
-57% -$105K ﹤0.01% 1236
2024
Q3 		$165K Buy
+72,226
New +$220K 0.01% 1061
2022
Q4 		– Sell
-7,150
Closed -$16K – 1978
2022
Q3 		$16K Sell
7,150
-19,487
-73% -$55.6K ﹤0.01% 1380
2022
Q2 		$86K Buy
26,637
+13,254
+99% +$57.8K 0.01% 1188
2022
Q1 		$70K Buy
13,383
+7,981
+148% +$44.8K 0.01% 1119
2021
Q4 		$45K Buy
+5,402
New +$49.6K ﹤0.01% 1052
2021
Q3 		– Sell
-4,495
Closed -$41K – 1774
2021
Q2 		$41K Buy
4,495
+3,179
+242% +$36.3K ﹤0.01% 1104
2021
Q1 		$13K Buy
+1,316
New +$14.7K ﹤0.01% 1224

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantbot Technologies's NUVB Position: Q1 2026 in Review

Quantbot Technologies sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 1,695 shares — an estimated $15.2K sold.

Quantbot Technologies first reported a position in NUVB in Q1 2021 and held it in 10 quarters. The position peaked at $165K in Q3 2024. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Quantbot Technologies reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,695 Nuvation Bio shares in Q1 2026, an estimated $15.2K.
  • Quantbot Technologies first reported a position in Nuvation Bio in Q1 2021 and held it in 10 quarters.
  • Quantbot Technologies's Nuvation Bio position peaked at $165K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.